2021-09-24 07:30 To be competitive in today’s challenging economic, regulatory, and political environment, drug sponsors must reduce product development time, terminate unpromising candidates sooner, improve patient-recruitment capabilities, enhance the protocol design process, control development costs, maintain quality, focus on areas of high therapeutic need, and dramatically boost productivity. CD BioSciences’ experts could help you through all clinical phases in all statistical aspects.